Gaush Meditech Ltd was listed on the Main Board of the Stock Exchange on December 12, 2022. With over 20 years of track record, Gaush Meditech, as a leading player in China’s ophthalmic medical device market, develops and distributes a broad spectrum of ophthalmic medical equipment and consumables, and also provides its end customers with related technical services. The Group’s product portfolio comprised Proprietary Products which the Group develops and manufactures as well as Distribution Products of its brand partners which the Group distributes, covering all seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for their diagnosis, treatment or surgeries, being vitreoretinal diseases, cataracts, refractive surgery, glaucoma, ocular surface diseases, optometry and pediatric ophthalmology.
No Data
No Data